Life

Health, science, climate, and society-focused reporting.

Maryland's Affordability Board Takes Action on Diabetes Medication Pricing

In a significant move, Maryland's State Affordability Board has initiated a process to establish a price cap for Jardiance, a medication for type 2 diabetes, with a target date set for January 2027.

editorial-staff Apr 14

Life

FDA Urges Drugmakers to Address Unreported Clinical Trial Results

An FDA analysis reveals that almost 30% of clinical trials, likely subject to mandatory reporting, have not submitted their results, prompting calls for accountability from drug manufacturers.

editorial-staff Apr 13

Life

Health Tech Firm Adapts for Medicare's Chronic Care Initiative

A remote patient monitoring company is adapting its technology to participate in Medicare's ACCESS experiment, which aims to improve health care outcomes through aligned payments.

editorial-staff Apr 13

Life

Trump's Approach to Health Insurance Raises Questions

Despite President Trump's promises to challenge health insurers, his policies appear to contradict those commitments, suggesting a softer stance.

editorial-staff Apr 13

Life

Revolution Medicines Reports Promising Data for Pancreatic Cancer Treatment

In a recent trial, patients with metastatic pancreatic cancer who received a new medication from Revolution Medicines reportedly lived twice as long as those treated with chemotherapy.

editorial-staff Apr 13

Life

Navigating the Challenges of Elevating Nurses to Health Expert Roles

As the healthcare landscape evolves, the transition of nurses into expert roles presents both opportunities and challenges, with implications for future healthcare delivery.

editorial-staff Apr 13

Life

Promising Advances in Allogene Therapeutics’ CAR-T Treatment for B-cell Lymphoma

Recent findings indicate that Allogene Therapeutics’ CAR-T therapy effectively targets residual cancer cells in B-cell lymphoma patients, potentially delaying recurrence.

editorial-staff Apr 13

Life

Spyre Therapeutics' IBD Drug Demonstrates Potential in Initial Trials

Spyre Therapeutics has reported positive results from its first major trial of a drug aimed at treating inflammatory bowel disease, positioning itself against larger pharmaceutical companies.

editorial-staff Apr 13

Life

Hospitals Introduce Chatbots to Improve Patient Interaction

Several hospitals are beginning to implement chatbots, a bold move intended to enhance communication with existing patients while attracting new ones.

editorial-staff Apr 13

Life

Understanding Erectile Dysfunction: A Broader Perspective

Erectile dysfunction extends beyond mere sexual concerns, impacting various aspects of life and well-being.

editorial-staff Apr 13

Life

Challenges Ahead for Vinay Prasad’s Successor at the FDA

The position of head of the FDA's Center for Biologics Evaluation and Research presents significant challenges for any successor.

editorial-staff Apr 13